Due to system upgrades, please note the following. Orders placed will be processed in 1-2 business days but may incur a slight delay in fulfillment. Learning activities ordered will be available immediately after order placement.
CAP is committed to processing orders as quickly and securely as possible during this upgrade. Thank you for your patience.

Welcome

Ordering and Supplemental Information

Proficiency Testing/EQA

Quality Management Tools

Learning

Publications

Error

JavaScript is disabled on your browser. JavaScript needs to be turned on for the application to be fully functional.

Proficiency Testing/EQA / 2025 Surveys / Microbiology /

Molecular Microbiology

Help

Please log in to determine if you are eligible to purchase PT Programs.

INFECTIOUS DISEASE, RESPIRATORY PANEL - IDR

IDR

Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte	Challenges per Shipment	Number of Shipments

Adenovirus	5	Three shipments per year
Bocavirus	5
Bordetella (pertussis, parapertussis, bronchiseptica, holmesii)	5
Chlamydia pneumoniae	5
Coronavirus	5
Human metapneumovirus	5
Influenza A	5
Influenza B	5
Legionella pneumophilia	5
Mycoplasma pneumoniae	5
Parainfluenza	5
Respiratory syncytial virus (RSV)	5
Rhinovirus/Enterovirus	5
SARS-CoV-2*	5

For programs that include more than one subspecialty of microbiology, per CLIA, your laboratory is required to test five specimens, three times a year, for each subspecialty your laboratory performs.

*SARS-CoV-2 specimens do not contain human genomic nucleic acid or human RNase P gene.

Program Information

Five 1.0-mL liquid specimens
Designed for molecular multiplex panel users

Shipping Schedule

Shipment A: February 24
Shipment B: June 30
Shipment C: November 17

Guest

Customers Who Bought This Item Also Bought